Clinical trial

Kinetic of Immune Memory Response After Re-Vaccination With Meningococcal…

NCT00262015 · Chiron Corporation, Industry · Unknown status

Key facts

NCT number NCT00262015
Title Kinetic of Immune Memory Response After Re-Vaccination With Meningococcal Vaccine
Official title A Phase IV, Single Center, Open-Label, Controlled, Randomized Study to Evaluate the Memory Response of Children Previously Vaccinated With Chiron Meningococcal C Conjugate Vaccine, Menjugate® and Describe the Kinetic of the Antibody Response and Maturation on Days 2-7 and 28 After Challenge With…
Lead sponsor Chiron Corporation, Industry
Status Unknown status
Phase Phase 4
Study type Interventional
Conditions Meningococcal Disease, Meningococcal Meningitis
Intervention type Biological
Interventions · Meningococcal C conjugate vaccine, Meningococcal A/C Polysaccharide vaccine (partial dose)
Enrollment 264
Start date Sep 1, 2003
First posted Dec 6, 2005
Last update posted Dec 6, 2005
Countries United Kingdom

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies